Maze Therapeutics, Inc.
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| – | – | – | -100.0% | |
| – | +7.0% | -19.4% | -27.1% | |
| – | – | – | -101.4% | |
| – | -16.2% | +12.9% | +29.9% | |
| – | +7.8% | +7.4% | +30.4% | |
| – | -11.2% | +11.5% | +27.8% | |
| – | – | – | -348.1% | |
| – | – | – | -345.5% | |
| – | – | – | – | |
| – | – | – | -351.0% | |
| – | – | – | -327.0% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.